MHRA approves aumolertinib to treat non-small cell lung cancer
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 3 June 2025, approved aumolertinib (Aumseqa) for adult patients with...
approves
WHA Approves Landmark Resolutions On Health Finance, Rare Diseases And Skin Diseases
Saturday’s WHA session saw the approval of multiple resolutions, including new measures on health finance, rare disease and skin diseases....
FDA Approves Bimzelx for Inflammatory Skin Disease
hidradenitis suppurativa © Lea - stock.adobe.comUCB announced today that the FDA has approved Bimzelx (bimekizumab-bkzx) for the treatment of moderate-to-severe...
US FDA approves Amgen drug for small cell lung cancer, Health News, ET HealthWorld
London: The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults...
